Prognostic influence of p53 nuclear overexpression in colorectal carcinoma

Diseases of the Colon and Rectum

Volumn 43, Issue 7, 2000, Pages 971-975

  Galindo Gallego, M ^a   Fernandez Acenero M J ^b   Sanz Ortega, J ^c   Aljama Delgado, A ^b   Balibrea Cantero, J L ^c  

^a Servicio Madrileño de Salud   (Spain)

^b HOSPITAL DE MÓSTOLES   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Colorectal carcinoma; p53; Prognosticators

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; COLORECTAL CARCINOMA; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; GENE DELETION; GENE LOCATION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME;

EID: 18244423844     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02237362     Document Type: Article

References (35)

1. De Vita VT, Hellman S, Rosemberg SA. Cancer. Principles and practice of oncology. 4th ed. Philadelphia: JB Lippincott, 1993:923.
2. Morris DL. Colorectal neoplasia: epidemiology and aetiology. Curr Opin Gastroenterol 1990;6:24-32.
3. Patel SC, Toveee EB, Langer B. Twenty-five years of experience with radical surgical treatment of carcinoma of the extraperitoneal rectum. Surgery 1977;82:460-5.
4. Linzer DI, Levine AJ. Characterization of a 54k dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 1979;17:43-52.
5. Nigro JM, Baker SJ, Preisinger AC, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature 1989;342:705-8.
6. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992;70:523-6.
7. Lane DP. p53, guardian of the genome. Nature 1992; 358:15-6.
8. Silvestrini R, Benini E, Daidone MG, et al. p53 as an independent prognostic marker in lymph node-negative breast cancer patients. J Natl Cancer Inst 1993; 85:965-70.
9. Quinlan DC, Davidson AG, Summers CL, Warden HE, Doshi HM. Accumulation of p53 protein correlates with poor prognosis in human lung cancer. Cancer Res 1992; 52:4828-31.
10. Ebina M, Steinberg SM, Mulshine JL, Linnoila RI. Relationships of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Cancer Res 1994;54:2496-503.
11. Uhlman DL, Nguyen PL, Manivel JC, et al. Association of immunohistochemical staining for p53 with metastatic progression and poor survival in patients with renal cell carcinoma. J Natl Cancer Inst 1994;86:1470-5.
12. Sarkis SA, Dalbagni G, Gordon Cardo C, et al. Association of p53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder. J Urol 1994;152:388-92.
13. Ito K, Watanabe K, Nasim S, et al. Prognostic significance of p53 overexpression in endometrial cancer. Cancer Res 1994;54:4667-70.
14. Henriksen R, Strang P, Wilander E, et al. p53 expression in epithelial ovarian neoplasms: relationship to clinical and pathological parameters, Ki-67 expression and flow cytometry. Gynecol Oncol 1994;53:301-6.
15. Joypaul BV, Hopwood D, Newman EL, et al. The prognostic significance of the accumulation of p53 tumor-suppressor gene protein in gastric adenocarcinoma. Br J Cancer 1994;69:943-6.
16. Fernandez-Aceñero MJ, Galindo M, Aragoncillo P, Fariña J. Vascular enumeration as a prognosticator for invasive breast carcinoma. J Clin Oncol 1998;16:1684-8.
17. Kawai A, Noguchi M, Beppu Y, et al. Nuclear immunoreaction of p53 protein in soft tissue sarcomas: a possible prognostic factor. Cancer 1994;73:2499-505.
18. Zhang ZF, Zhang ZS, Sarkis AS, et al. Family history of cancer, body weight, and p53 overexpression in Duke's C colorectal cancer. Br J Cancer 1995;71:888-93.
19. Sjögren S, Inganas M, Norberg T, et al. The p53 gene in breast cancer; prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst 1996;88:173-82.
20. Scott N, Sagar P, Stewart J, Blair GE, Dixon MF, Quirke P. p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer 1991;63:317-9.
21. Yamaguchi A, Kurosaka Y, Fushida S, et al. Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis. Cancer 1992;70:2778-84.
22. Zeng ZS, Sarkis AS, Zhang ZF, et al. p53 nuclear overexpression: an independent predictor of survival in lymph node-positive colorectal cancer patients. J Clin Oncol 1994;12:2043-50.
23. Takahashi Y, Bucana CD, Cleary KR, Ellis LM. p53, vessel count and vascular endothelial growth factor expression in human colon cancer. Int J Cancer 1998;79:34-8.
24. Manne U, Myers RB, Moron C, et al. Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma. Int J Cancer 1997;74:346-58.
25. Mulder JW, Baas IO, Polak MM, et al. Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma. Br J Cancer 1995;71:1257-62.
26. Manne U, Weiss HL, Myers RB, et al. Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor. Cancer 1998;83:2456-67.
27. Sun XF, Carstenser JM, Stal O, et al. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 1992;340:1369-73.
28. Tollenaar RA, van Krieken JH, van Slooten HJ, et al. Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance. Br J Cancer 1998;77:1842-7.
29. Chen YT, Henk MJ, Carney KJ, et al. Prognostic significance of tumor markers in colorectal cancer patients: DNA index, S-phase fraction, p53 expression, and Ki-67 index. J Gastrointest Surg 1997;1:266-73.
30. Pereira H, Silva S, Juliao R, Garcia P, Perpetua F. Prognostic markers for colorectal cancer: expression of p53 and Bcl2. World J Surg 1997;21:210-3.
31. Nathanson SD, Linden MD, Tender P, Zarbo RJ, Jacobsen G, Nelson LT. Relationship among p53, stage and prognosis of large bowel cancer. Dis Colon Rectum 1994;37:527-34.
32. Sun XF, Carstenser JM, Stal O, et al. Prognostic significance of p53 expression in relation to DNA ploidy in colorectal adenocarcinoma. Virchows Arch A Pathol Anal Histopathol 1993;423:443-8.
33. Flamini G, Curigliano G, Ratto C, et al. Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer. An immunohistochemical analysis. Eur J Cancer 1996;32:802-6.
34. Wu X, Boyle JH, Olson DC, Levine AJ. The p53-mdm2 autoregularory feed-back loop. Genes Dev 1993;7: 1126-32.
35. Prioleau J, Schnitt SJ. p53 antigen loss in stored paraffin slides. N Engl J Med 1995;22:1521-2.